10/66 Dementia Research Group Alzheimer's Disease International

Population-based epidemiological studies (incidence phase)

The cooperation of the local community is essential – older peer mentors encouraged participation in Lima, Peru

The 10/66 Dementia Research Group has just begun a 2.5 to three year incidence phase follow-up of the baseline sample. The incidence phase will exploit the rich baseline cross-sectional data in the six Latin American countries (Cuba, Dominican Republic, Venezuela, Mexico, Peru and Argentina) and in China to assess risk factors for incident dementia, stroke and mortality. Verbal autopsy will be used to identify causes of death. The incidence phase will involve approximately 15,000 older people.

First results should be available in early 2009, and the incidence phase will be completed in 2010.



The following centres received direct funding support for their research program:

  • Peru, Mexico, Argentina, Cuba, Dominican Republic, Venezuela and China - The Wellcome Trust Health Consequences of Population Change Programme; (GR08002)
  • India - The Wellcome Trust Health Consequences of Population Change Programme (Master’s level fellowship for Mr Jotishwaran)

Latest 10/66 News

  • Professor Martin Prince contributes to the Lancet Commission on Global Mental Health and Sustainable Development
  • Access our latest publications here (as of July 2018)
  • Follow us on Twitter @1066_DRG for more updates
  • Watch Alzheimer's Disease International's production exploring the risks, growth and future response to dementia - "Every Three Seconds"

© 2008-2015 10/66 Dementia Research Group. Terms of Use